Has Earl Labovitz received payments from drug or device companies?

Yes. Drug and device makers reported $2,389 in general payments to Earl Labovitz across 81 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Earl Labovitz did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Earl Labovitz come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Earl Labovitz

Allergy & Immunology · Gilbert, AZNPI 1447210935

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AstraZeneca at 31.9% of the total. Reporting peaked in 2019 at $667 and has fallen 56.1% since, to $293 in 2023. That places this record below the midpoint for allergy & immunology clinicians in AZ, where the typical reported total is $2,389.

$2,389in general payments, 2019–2025

Across 81 payments — averaging $29.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$761
Regeneron Healthcare Solutions, Inc.$368
Sanofi$130
GSK$129
Pharming Healthcare, Inc.$128
Alk-abello, Inc$123
plus $751 from 15 others

What the payments were for

Food & beverage$2,389100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	19	$761
Regeneron Healthcare Solutions, Inc.	24	$368
Sanofi	2	$130
GSK	5	$129
Pharming Healthcare, Inc.	2	$128
Alk-abello, Inc	1	$123
Optinose US, Inc.	4	$122
Biocryst Pharmaceuticals, Inc.	1	$98
Takeda Pharmaceuticals U.S.A., Inc.	2	$87
Kaleo, Inc.	3	$65
Novartis	3	$62
AbbVie	2	$49
Circassia Inc.	1	$48
Teva Pharmaceuticals USA, Inc.	3	$45
Octapharma USA, Inc.	2	$41
Genentech USA, Inc.	1	$40
Amgen	2	$30
Pfizer	1	$19
Merck	1	$19
Grifols USA, LLC	1	$13
Eyevance Pharmaceuticals LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,389 in reported general payments places this provider in the 50th percentile of 90 allergy & immunology providers in Arizona.

See all allergy & immunology providers in Arizona →

Other allergy & immunology in Gilbert

Neal JainGilbert$388K
Sam ShimamotoGilbert$36K
Doina LapusanGilbert$1K
Michael ManningScottsdale$1.1M
Jennifer HillScottsdale$335K
Jean NelsonScottsdale$183K
Kiranjit KhalsaScottsdale$124K
Keith SaccoPhoenix$118K
Jacob MadduxSurprise$87K
Tara CarrTucson$76K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →